Conservative treatment for injuries of the medial collateral ligament using platelet rich plasma (PRP) and hight intensity laser (HIL)
ESSKA Academy. Vassilev I. 11/08/19; 284457; epESMA-66 Topic: Sports Related Injuries
Dr. Ivan Vassilev
Dr. Ivan Vassilev
Login now to access Regular content available to all registered users.

You can access free regular educational content on the ESSKA Academy by registering as an 'ESSKA Academy User’ here

Access to Premium content is currently a membership benefit.

Click here to join ESSKA or renew your membership.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Conservative treatment for injuries of the medial collateral ligament using platelet rich plasma (PRP) and hight intensity laser (HIL)

ePoster - epESMA-66

Topic: Sports Trauma

Vassilev I., Filipov N., Paskaleva S.
Eurovita Sports Clinic, Sofia, Bulgaria

Introduction: The injury of the medial collateral ligament (MCL) is a very common injury in contact sport. We use conservative treatment in grade 1 and 2 injury and aoperative treatment in grade 3. For years we we use combination of PRP and HIL for treatment of partial ruptures of MCL in sports related traumas.
Objectives: We present our 6 years of experience with treatment of injuries of the medial collateral ligament of the knee using a combination of PRP and HIL.
Methods: For the period from September 2013 till March 2019 we had 97 professional or semi-professional soccer players with isolated injuries of the Medial Collateral Ligament (MCL).
The age of the patients varied from 14 to 37 years. The patients were treated between 1 and 4 days after the injury. The type of injury was evaluated both clinically and with Magnetic Resonance Imaging (MRI).
We treated with PRP only patients without clinically proved high grade instability and with grade I or II evaluated on the MRI examination.
We used three PRP injections (PlasmoliftingTM ) with approximately one week interval./1,2,3/
The HIL was used immediately before and after the PRP. We used BTL- 6000 SWT 4 procedures - the first one at the initial visit and immediately after each PRP injection. Analgesic phase - with parameters: power 9W, at a dose of 11 J / cm2, in pulse mode, duration 2 min.
Biostimulating phase - with parameters: power 5-12 W, at a dose of 110-140 J/cm2, in constant dose-adjusted mode, on average between 2-6 min
The first PRP procedure was performed immediately after the MRI./1/
No use of Non-Steroidal Anti-Inflammatory Drugs was allowed during the procedures.
During the treatment we used individual rehabilitation protocol (the number, the type of procedures and the length of procedures depends on the injury and the patient reaction).
We evaluated the results using the Tegner Activity Level Scale.
The score was evaluated at the initial visit, after the second procedure and one week after the third one.
The criteria for Return to Play are full range of movements and Tegner Activity Level Scale above 8.0.
Results: The average results of the Tegner Activity Level Scale at the first visit were 1.85 (range: 0-2); the second visit 2.76 (range: 1-3) and after the third 8.96 (range: 8-10).
Conclusios: The use of HIL and PRP is a reliable and minimally invasive method for treatment of injuries grade I and II of the collateral ligaments of the knee.
Conservative treatment for injuries of the medial collateral ligament using platelet rich plasma (PRP) and hight intensity laser (HIL)

ePoster - epESMA-66

Topic: Sports Trauma

Vassilev I., Filipov N., Paskaleva S.
Eurovita Sports Clinic, Sofia, Bulgaria

Introduction: The injury of the medial collateral ligament (MCL) is a very common injury in contact sport. We use conservative treatment in grade 1 and 2 injury and aoperative treatment in grade 3. For years we we use combination of PRP and HIL for treatment of partial ruptures of MCL in sports related traumas.
Objectives: We present our 6 years of experience with treatment of injuries of the medial collateral ligament of the knee using a combination of PRP and HIL.
Methods: For the period from September 2013 till March 2019 we had 97 professional or semi-professional soccer players with isolated injuries of the Medial Collateral Ligament (MCL).
The age of the patients varied from 14 to 37 years. The patients were treated between 1 and 4 days after the injury. The type of injury was evaluated both clinically and with Magnetic Resonance Imaging (MRI).
We treated with PRP only patients without clinically proved high grade instability and with grade I or II evaluated on the MRI examination.
We used three PRP injections (PlasmoliftingTM ) with approximately one week interval./1,2,3/
The HIL was used immediately before and after the PRP. We used BTL- 6000 SWT 4 procedures - the first one at the initial visit and immediately after each PRP injection. Analgesic phase - with parameters: power 9W, at a dose of 11 J / cm2, in pulse mode, duration 2 min.
Biostimulating phase - with parameters: power 5-12 W, at a dose of 110-140 J/cm2, in constant dose-adjusted mode, on average between 2-6 min
The first PRP procedure was performed immediately after the MRI./1/
No use of Non-Steroidal Anti-Inflammatory Drugs was allowed during the procedures.
During the treatment we used individual rehabilitation protocol (the number, the type of procedures and the length of procedures depends on the injury and the patient reaction).
We evaluated the results using the Tegner Activity Level Scale.
The score was evaluated at the initial visit, after the second procedure and one week after the third one.
The criteria for Return to Play are full range of movements and Tegner Activity Level Scale above 8.0.
Results: The average results of the Tegner Activity Level Scale at the first visit were 1.85 (range: 0-2); the second visit 2.76 (range: 1-3) and after the third 8.96 (range: 8-10).
Conclusios: The use of HIL and PRP is a reliable and minimally invasive method for treatment of injuries grade I and II of the collateral ligaments of the knee.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies